Why the study?
Does a fixed combination of amlodipine, lisinopril and rosuvastatin improve lipid levels, blood pressure, and vascular stiffness markers in patients with hypertension and nonstenotic atherosclerosis of brachiocephalic arteries?
Observational (n=113)
Does a fixed combination of amlodipine, lisinopril and rosuvastatin improve lipid levels, blood pressure, and vascular stiffness markers in patients with hypertension and nonstenotic atherosclerosis of brachiocephalic arteries?
Answers are grounded in this paper and cite their sources.
A fixed combination of amlodipine, lisinopril, and rosuvastatin effectively lowers LDL cholesterol in patients with hypertension and nonstenotic atherosclerosis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Бланкова et al. (2017) conducted an observational in hypertension and nonstenotic atherosclerosis of brachiocephalic arteries (n=113). fixed combination of amlodipine, lisinopril and rosuvastatin vs. baseline was evaluated on LDL levels.
Synapse has enriched 10 related papers. Consider them for comparative context: